Sure they do, but it's very hard to market illegal activities in a b2b context. How does 23andMe go about selling data allowing insurers to discriminate, without saying that's what they do?

I can think of a few things you could try, maybe. But judging from 23andMe's present state, it's clear that whatever things they tried to monetize customers' DNA info, didn't work out well for them.